Vaccine manufacturer Serum Institute of India is now going to invest heavily in vaccine facilities in the United Kingdom. British Prime Minister Boris Johnson gave this information on Monday. He also said that the company could also manufacture the vaccine in the UK in the future. The Prime Minister’s Office announced on behalf of the Downing Street office that the company would invest 240 million British pounds ($ 334 million), including a sales office for ‘clinical trials, research, development and possibly the manufacture of vaccines’ I will go
Let us know that the Serum Institute is the largest vaccine manufacturer in the world in terms of volume and has been in the forefront of making cheap AstraZeneca vaccine against coronavirus. SII has also started a trial in the first phase of one of their dose-based vaccine vaccines in the UK.
The British Prime Minister’s Office said that SII’s investment plan is part of a $ 1 billion trade and investment deal with India, which is expected to generate 6,500 jobs. This investment announcement comes when a virtual conference is to be held on Tuesday between British Prime Minister Boris Johnson and Indian Prime Minister Narendra Modi.
Adar Poonawala clarifies, pressures for vaccine supply misinterpreted
Since separating from the European Union last year, Britain has been giving preference to India for investment and trade. Boris Johnson was scheduled to visit India at the beginning of the year, but his trip has been postponed twice due to Kovid. By the time before the second wave of Corona, India was exporting SII-manufactured AstraZeneca vaccine to economically weaker countries under the Kovacs scheme. However, due to increasing cases of Corona, its exports were banned last month.
SII is producing 60-70 million AstraZeneca doses every month and aims to reach it at 100 million by July.
(This news has not been edited by the NewsBust team. It has been published directly from the Syndicate feed.)